Chair of Neurosurgery
University of Toronto
TORONTO, Ontario, Canada
Dr. Gelareh Zadeh, MD, PhD, FRCS(C), FAANS, is Dan Family Chair and Professor of Neurosurgery, University of Toronto. She is Harold & Esther Halpern Chair and Head of the Division of Neurosurgery at Toronto Western Hospital and Co-Director for the Krembil Brain Institute at University Health Network.
Dr. Zadeh has a dedicated skull base and neuro-oncology practice, with a number of multidisciplinary specialized programs including a skull base clinic, brain metastases, pituitary clinic, and neurofibromatosis clinics.
Dr. Zadeh is a Senior Scientist at Princess Margaret Cancer Centre where she runs a translational research program at MacFeeters-Hamilton Neuro-oncology Program and holds the Wilkins Family Brain Tumor Research Chair. She has an active research laboratory focusing on integrated multi-platform molecular analysis of brain tumors, together with a focus on understanding molecular response to targeted therapies, such as anti-angiogenesis and metabolic inhibitors. She has published impactful investigative research in Cancer Cell, Nature Communication, Nature, Nature Medicine and her research has translated to direct advances in clinical care. She has consistent peer-review funding from CIHR, NIH, DOD, CCS, Terry Fox, Brain Tumor Charity, UK. Her contributions have been recognized through awards such as most recently the prestigious Gairdner Momentum Award, the P. Rawl Prize from Canadian Cancer Research Society, American Brain Tumor Translational Research Award and many others.
She is also involved in a number of national and international organizations. She served as the President of Society of Neuro-Oncology (SNO), Scientific Chair of Tumor Section of American Association of Neurological Surgery/Congress of Neurological Surgeons, Chair of Women in Neurosurgery Committee, WFNS as well as being the co-founder of the International Consortium on Meningiomas (ICOM) and Editor-in-Chief of Neuro-Oncology Advances, an open access journal of SNO and EANO.
Disclosure(s): No financial relationships to disclose
Saturday, May 4, 2024
2:27 PM – 2:29 PM CT
Sunday, May 5, 2024
2:31 PM – 2:33 PM CT
Methylation Profiling of CNS Tumors
Monday, May 6, 2024
8:11 AM – 8:30 AM CT
How Could This Work Under a Single Payor: Canada
Monday, May 6, 2024
7:32 AM – 7:52 AM CT